There are several treatments for multiple sclerosis; however, this paper will focus on two treatments widely used in managing this disease: Interferon-β (IFN-β) and dimethyl fumarate (DMF) (Reick et al., 2014). This evidence concerns the gene IFNB1 and multiple sclerosis.